Author

Rieke Schleinhege

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Aya MatsuiiD· 1 shared Chengzhan ZhuiD· 1 shared Dan Gabriel DudaiD· 1 shared Dandan YuaniD· 1 shared Jianguo WangiD· 1 shared Kassiana MafraiD· 1 shared Ken KojoiD· 1 shared Kento Miyazaki· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aya MatsuiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma

Xin Liu, Zelong Liu, Chengzhan Zhu, Tatsuya Kobayashi, Pin‐Ji Lei, Yue Shi, Dandan Yuan, Jianguo Wang, Min Li, Aya Matsui, Kassiana Mafra, Tomofumi Ando, Ken Kojo, Rieke Schleinhege, Kento Miyazaki, , Dan Gabriel Duda

This study shows that B-cell depletion or TIM-1 targeting enhances immunotherapy efficacy in HCC by reducing B-cell-mediated immunosuppression and improving antigen presentation.

Nature Communications · Dec 8, 2025Peer-reviewedCancer Biology